Chong Kun Dang Pharmaceutical Corp (185750) Fair Value & Analysis
Healthcare · KR · Market cap 933B KRW
Fair value as of: Jun 24, 2026
Analysis
Chong Kun Dang Pharmaceutical Corp (185750) currently trades at 66,900 KRW, while our model-based Fair Value estimate is 115,734 KRW — implying the stock looks roughly 73.0% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.
About the company
Chong Kun Dang Pharmaceutical Corp. manufactures, markets, and sells medicines in South Korea and internationally. It offers prescription drugs for anti-hypertension, anti-hyperlipidaemia, and anti-diabetics, as well as immunosuppressants; over-the-counter medicines; and consumer health products, such as insecticides and hair dye products, as well as health supplements. The company was founded in 1941 and is headquartered in Seoul, South Korea.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is Chong Kun Dang Pharmaceutical Corp (185750) undervalued?
What is the fair value of 185750?
What is the quality score of 185750?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.